The San Antonio Breast Cancer Symposium (SABCS) 2021 saw ground-breaking data and developments in breast cancer being presented and in this special podcast, leading breast cancer experts Hope Rugo (UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA) and Dave Cescon (Princess Margaret Cancer Center, Toronto, Canada), dissect the latest advances in the field and offer their unique perspectives.

Listen to this insightful roundtable discussion to learn about the latest clinical trial data in breast cancer, including pivotal developments from the KEYNOTE-522 and KEYNOTE-355 trials, which assessed pembrolizumab in triple-negative breast cancer. Developments in antibody-drug conjugates (ADCs) and the role of oral selective estrogen receptor degraders (SERDs) including elacestrant, following findings from EMERALD trial, are additionally examined.